These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19538508)

  • 1. Identification and characterization of kava-derived compounds mediating TNF-alpha suppression.
    Pollastri MP; Whitty A; Merrill JC; Tang X; Ashton TD; Amar S
    Chem Biol Drug Des; 2009 Aug; 74(2):121-8. PubMed ID: 19538508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Kavain Analog with Efficient Anti-inflammatory Effects.
    Huck O; Han X; Mulhall H; Gumenchuk I; Cai B; Panek J; Iyer R; Amar S
    Sci Rep; 2019 Sep; 9(1):12940. PubMed ID: 31506483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Articular and Systemic Inflammation by Kava-241 in a Porphyromonas gingivalis-Induced Arthritis Murine Model.
    Huck O; You J; Han X; Cai B; Panek J; Amar S
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29914930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kavain Involvement in LPS-Induced Signaling Pathways.
    Tang X; Amar S
    J Cell Biochem; 2016 Oct; 117(10):2272-80. PubMed ID: 26917453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of kava constituents in an in vitro model of oral mucositis.
    Yiannis C; Huang K; Tran AN; Zeng C; Dao E; Baselyous O; Mithwani MA; Paolini R; Cirillo N; Yap T; McCullough M; Celentano A
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1801-1811. PubMed ID: 32435894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and synthesis of TNF-alpha release inhibitors from Fijian kawa (Piper methysticum).
    Hashimoto T; Suganuma M; Fujiki H; Yamada M; Kohno T; Asakawa Y
    Phytomedicine; 2003 May; 10(4):309-17. PubMed ID: 12809361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutical evaluation of kavain in Piper methysticum G. Forst dried extract: Equilibrium solubility and intestinal permeability in Caco-2 cell model.
    Santos RRDS; Ramos MC; Ferreira JV; Gonçalves JE; César IC
    J Ethnopharmacol; 2022 Oct; 296():115480. PubMed ID: 35716919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.
    Chua HC; Christensen ET; Hoestgaard-Jensen K; Hartiadi LY; Ramzan I; Jensen AA; Absalom NL; Chebib M
    PLoS One; 2016; 11(6):e0157700. PubMed ID: 27332705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kavain attenuates vascular contractility through inhibition of calcium channels.
    Martin HB; McCallum M; Stofer WD; Eichinger MR
    Planta Med; 2002 Sep; 68(9):784-9. PubMed ID: 12357387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography-tandem mass spectrometry bioanalytical method for the determination of kavain in mice plasma: Application to a pharmacokinetic study.
    Ferreira JV; Braga AV; Machado RR; Michel D; Pianetti GA; El-Aneed A; César IC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121939. PubMed ID: 31877429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption.
    Guo Q; Cao Z; Wu B; Chen F; Tickner J; Wang Z; Qiu H; Wang C; Chen K; Tan R; Gao Q; Xu J
    J Cell Physiol; 2018 Jan; 234(1):789-801. PubMed ID: 30078210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]-monoamine uptake inhibition properties of kava pyrones.
    Seitz U; Schüle A; Gleitz J
    Planta Med; 1997 Dec; 63(6):548-9. PubMed ID: 9434608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review.
    Grunze H; Langosch J; Schirrmacher K; Bingmann D; Von Wegerer J; Walden J
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Nov; 25(8):1555-70. PubMed ID: 11642654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of Kav001 in inhibition of LPS/P. gingivalis-induced.
    Tang X; Alasiri M; Bamashmous A; Aljahdali B; Cao F; Dibart S; Salih E
    J Cell Biochem; 2018 Jul; 119(7):6072-6079. PubMed ID: 29637600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The action profile of D,L-kavain. Cerebral sites and sleep-wakefulness-rhythm in animals].
    Holm E; Staedt U; Heep J; Kortsik C; Behne F; Kaske A; Mennicke I
    Arzneimittelforschung; 1991 Jul; 41(7):673-83. PubMed ID: 1772452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of (+/-)-kavain on population spikes and long-term potentiation in guinea pig hippocampal slices.
    Langosch JM; Normann C; Schirrmacher K; Berger M; Walden J
    Comp Biochem Physiol A Mol Integr Physiol; 1998 Jul; 120(3):545-9. PubMed ID: 9787833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute oral toxicity, antinociceptive and antimicrobial activities of kava dried extracts and synthetic kavain.
    Ferreira JV; Pierotte IC; Rodrigues FF; Souza LCR; Bastos RW; Carmo PHF; Cassali GD; Tagliati CA; Machado RR; Santos DA; Pianetti GA; César IC
    Nat Prod Res; 2022 Aug; 36(16):4221-4226. PubMed ID: 34491148
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives.
    Folmer F; Blasius R; Morceau F; Tabudravu J; Dicato M; Jaspars M; Diederich M
    Biochem Pharmacol; 2006 Apr; 71(8):1206-18. PubMed ID: 16464438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.